Nunes Anne bought ANIK
March 14, 2025 · Form 4 insider transaction
Nunes Anne bought 20,761 shares of Anika Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
20,761
Price
$0.00
Total value
N/A
InsiderNunes Anne
Role—
SecurityRestricted Stock Unit
Transaction codeA: Grant or award
Transaction dateMarch 14, 2025
Filing dateMarch 18, 2025
Shares owned after20,761
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Each RSU represents the contingent right to receive, at the Company's discretion, one share of the Company's common stock, or the cash equivalent of the closing price of one share of the Company's common stock, on each vest date. The RSUs vest in three equal annual installments beginning March 14, 2026.